Drug Shortage Report for TEVA-NYSTATIN
Report ID | 113034 |
Drug Identification Number | 02194201 |
Brand name | TEVA-NYSTATIN |
Common or Proper name | NYSTATIN 100MU/ML DROP |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | NYSTATIN |
Strength(s) | 100000UNIT |
Dosage form(s) | SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 1L |
ATC code | A07AA |
ATC description | INTESTINALANTIINFECTIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-04-22 |
Estimated end date | 2020-11-30 |
Actual end date | 2020-11-25 |
Shortage status | Resolved |
Updated date | 2020-11-26 |
Company comments | Allocating to 100% of our market. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2020-11-26 | English | Compare |
v10 | 2020-10-30 | French | Compare |
v9 | 2020-10-30 | English | Compare |
v8 | 2020-07-09 | French | Compare |
v7 | 2020-07-09 | English | Compare |
v6 | 2020-06-11 | French | Compare |
v5 | 2020-06-11 | English | Compare |
v4 | 2020-05-08 | French | Compare |
v3 | 2020-05-08 | English | Compare |
v2 | 2020-04-23 | French | Compare |
v1 | 2020-04-23 | English | Compare |
Showing 1 to 11 of 11